# US 2013/0211502 A1 · Method of using amnion allograft in coronary artery bypass grafting

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0211502 A1
- Document ID: US20130211502A1
- Status: Published application
- Kind: A1
- Application number: 13/767,204
- Filed: 2013-02-14
- Published: 2013-08-15
- Earliest claimed: 2012-02-14
- Assignees: Afcell Medical
- Inventors: Robin R. YOUNG
- Web page: https://patentgrep.com/patent/US20130211502A1

## CPC

- A61F 2/06: Blood vessels
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Improved methods for coronary artery bypass grafting surgeries are described. The methods utilize an allograft comprising a layer of amnion to improve the performance and reduce complications of the surgeries and the allograft has a pre-made size and shape suitable for the application.

## Claims

### Claim 1

A method of improving a coronary artery bypass grafting surgery in a subject, comprising applying at least one of an amniotic fluid and an allograft comprising a layer of amnion over a suture line or incision, or an otherwise damaged tissue site resulting from the coronary artery bypass grafting surgery, or over or under the pericardium membrane of the subject

### Claim 2 (depends on 1)

The method of claim 1, wherein the allograft is attached to a tissue of the subject with a 4.0 suture.

### Claim 3 (depends on 1)

The method of claim 1, wherein the allograft has a thickness of about 0.02 mm to 0.10 mm.

### Claim 4 (depends on 1)

The method of claim 1, wherein the allograft applied over or under the pericardium membrane has an oval shape, about 3 cm to 9 cm in length and about 2 cm to 6 cm in width.

### Claim 5 (depends on 1)

The method of claim 1, wherein the allograft consists of a single layer of amnion, two layers of amnion, or a layer of amnion and a layer of chorion.

### Claim 6 (depends on 1)

The method of claim 1, wherein the allograft is applied after a bypass vessel graft is sutured in and the pericardial cavity is washed with a saline solution comprising one or more anti-microbial agents.

### Claim 7 (depends on 1)

The method of claim 1, wherein the allograft further comprises one or more therapeutically active agents selected from the group consisting of anti-microbial agents, growth enhancing agents, anti-inflammatory agents, and agents that prevent scarring, adhesions and tethering of internal organs and the heart.

### Claim 8 (depends on 1)

The method of claim 1, wherein the coronary artery bypass grafting is a traditional coronary artery bypass grafting, an off-pump coronary artery bypass grafting, or a minimally invasive direct coronary artery bypass grafting.

### Claim 9 (depends on 1)

The method of claim 1, further comprising placing a second allograft comprising a layer of amnion over a harvest site for a bypass vessel graft.

### Claim 10

A method of improving a coronary artery bypass grafting surgery, comprising placing an allograft comprising a layer of amnion over a harvest site for a bypass vessel graft.

### Claim 11 (depends on 10)

The method of claim 10, wherein the harvest site is a left internal mammary artery (LIMA) harvest site or a saphenous vein harvest site.

### Claim 12 (depends on 10)

The method of claim 10, wherein the allograft has a thickness of about 2 mm to 4 mm.

### Claim 13 (depends on 12)

The method of claim 12, wherein the allograft comprises multiple layers of amnion and optionally multiple layers of chorion.

### Claim 14 (depends on 10)

The method of claim 10, wherein the allograft has a rectangular shape, about 10 cm by 5 cm.

### Claim 15 (depends on 1)

The method of claim 1, wherein the amnion is obtained using a process comprising:
a. obtaining informed consent from pregnant females;
b. conducting risk assessment on the consented pregnant females to select an amnion donor;
c. procuring after birth placenta from the amnion donor; and
d. obtaining the amnion from the placenta.

### Claim 16

A kit comprising a plurality of allografts and instructions on how to use the allografts to improve a coronary artery bypass grafting surgery, wherein each of the plurality of allografts comprises a layer of amnion of a pre-made size and shape suitable for covering a suture line, an incision, or an otherwise damaged tissue site resulting from the coronary artery bypass grafting surgery, or for covering over or under the pericardium membrane of the subject.

### Claim 17 (depends on 16)

The kit of claim 16, wherein the amnion is obtained using a process comprising:
a. obtaining informed consent from pregnant females;
b. conducting risk assessment on the consented pregnant females to select an amnion donor;
c. procuring after birth placenta from the amnion donor; and
d. obtaining the amnion from the placenta.

### Claim 18 (depends on 16)

The kit of claim 16, comprising an allograft having a thickness of about 0.02 mm to 0.10 mm, and an oval shape of about 3 cm to 9 cm in length and about 2 cm to 6 cm in width.

### Claim 19 (depends on 18)

The kit of claim 18, further comprising a second allograft comprising a plurality layers of amnion, and optionally one or more layers of chorion, wherein the second allograft has a thickness of about 2 mm to 4 mm, and a rectangular shape of about 10 cm by 5 cm.

### Claim 20 (depends on 19)

The kit of claim 19 further comprising an amniotic fluid.
